OmniActive Health Technologies
Indian supplier of branded curcumin and lutein ingredients and a nutrient-delivery technology.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
OmniActive Health Technologies is an India-based specialty and botanical-actives ingredient supplier with branded ingredients including CurcuWIN (curcumin), Lutemax 2020 and Lutemax Free Lutein (carotenoids), and UltraSOL nutrient-delivery technology. Active M&A signal as of Q1 2026: Swedish private equity firm EQT is the sole bidder following rejection of a competing Temasek/Novo Holdings offer; valuation gap reported (~$1B hoped vs lower bids). The M&A signal reflects a healthy operating company exploring exit.
Certifications
0 of 1 certification independently confirmed. What this means
Capabilities
- PRODUCT TYPES
- CurcuWIN (curcumin) · Lutemax 2020 + Lutemax Free Lutein (carotenoids) · UltraSOL nutrient-delivery technology · Specialty and botanical actives
- CAPABILITIES
- Botanical extracts or ingredients · Branded or patented ingredients · Carotenoids · Delivery or absorption technology
Sources
- OmniActive CurcuWIN product page(2026-05-26)
- Whalesbook 2026 EQT-OmniActive M&A coverage(2026-05-26)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Current FDA GRAS Notice Inventory entries (if any) for Lutemax 2020 and CurcuWIN
- EQT acquisition close-or-collapse status
- ENovate Biolife portfolio integration scope
- Active M&A negotiations with EQT as of Q1 2026 — entity ownership may change post-deal-close; refresh entity status after Q3 2026 or upon deal closure (per Whalesbook 2026 reporting)
- Self-affirmed GRAS for CurcuWIN (NutraIngredients 2016) and FDA GRAS no-objection for Lutemax 2020 (NutraIngredients 2012) are stale trade-press references not added to certifications[] because GRAS is a regulatory notice not a third-party certification + Phase B did not locate current FDA GRAS Notice Inventory entries. Captured in assessmentRationale + sources[].
- OmniActive recently acquired ENovate Biolife (per PR Newswire); ingredient portfolio scope may expand or shift
- Discovery surface is SupplySide Global exhibitor (paid commercial relationship); direct OmniActive certification directory cross-check incomplete in Phase B
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between OmniActive Health Technologies and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Interested in OmniActive Health Technologies?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.